BR0109163A - Uso de pirido[3,2-e]-pirazinonas como inibidores da fosfodieterase 5, para terapia de disfunção erétil - Google Patents
Uso de pirido[3,2-e]-pirazinonas como inibidores da fosfodieterase 5, para terapia de disfunção erétilInfo
- Publication number
- BR0109163A BR0109163A BR0109163-8A BR0109163A BR0109163A BR 0109163 A BR0109163 A BR 0109163A BR 0109163 A BR0109163 A BR 0109163A BR 0109163 A BR0109163 A BR 0109163A
- Authority
- BR
- Brazil
- Prior art keywords
- inhibitors
- erectile dysfunction
- pyrazinones
- pyrido
- phosphodietherase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10012373A DE10012373A1 (de) | 2000-03-14 | 2000-03-14 | Verwendung von Pyrido[3,2-e]-pyrazinonen als Inhibitoren der Phosphodiesterase 5 zur Therapie von erektiler Dysfunktion |
PCT/EP2001/002485 WO2001068097A1 (de) | 2000-03-14 | 2001-03-06 | VERWENDUNG VON PYRIDO[3,2-e]-PYRAZINONEN ALS INHIBITOREN DER PHOSPHODIESTERASE 5 ZUR THERAPIE VON EREKTILER DYSFUNKTION |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0109163A true BR0109163A (pt) | 2002-11-26 |
Family
ID=7634668
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0109163-8A BR0109163A (pt) | 2000-03-14 | 2001-03-06 | Uso de pirido[3,2-e]-pirazinonas como inibidores da fosfodieterase 5, para terapia de disfunção erétil |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1267877A1 (bg) |
JP (1) | JP2003528056A (bg) |
AR (1) | AR028250A1 (bg) |
AU (1) | AU2001244192A1 (bg) |
BG (1) | BG107077A (bg) |
BR (1) | BR0109163A (bg) |
CZ (1) | CZ20023078A3 (bg) |
DE (1) | DE10012373A1 (bg) |
HU (1) | HUP0300551A2 (bg) |
IL (1) | IL151646A0 (bg) |
NO (1) | NO20024364L (bg) |
RU (1) | RU2002127413A (bg) |
SK (1) | SK13232002A3 (bg) |
WO (1) | WO2001068097A1 (bg) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0420722D0 (en) | 2004-09-17 | 2004-10-20 | Addex Pharmaceuticals Sa | Novel allosteric modulators |
TWI417095B (zh) | 2006-03-15 | 2013-12-01 | Janssen Pharmaceuticals Inc | 1,4-二取代之3-氰基-吡啶酮衍生物及其作為mGluR2-受體之正向異位性調節劑之用途 |
TW200845978A (en) | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
UA100126C2 (en) | 2007-09-14 | 2012-11-26 | Аддекс Фарма С.А. | 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-[1, 4'] bipyridinyl-2'-ones |
PT2200985E (pt) | 2007-09-14 | 2011-07-21 | Ortho Mcneil Janssen Pharm | 4-(aril-x-fenil)-1h-piridin-2-onas 1,3-dissubstituídas |
EP2225248A1 (en) | 2007-11-30 | 2010-09-08 | Wyeth LLC | Aryl and heteroaryl fused imidazo[1,5-a]pyrazines as inhibitors of phosphodiesterase 10 |
AU2009289784B2 (en) | 2008-09-02 | 2012-03-22 | Addex Pharma S.A. | 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors |
BRPI0921333A2 (pt) | 2008-11-28 | 2015-12-29 | Addex Pharmaceuticals Sa | derivados de indol e benzoxazina como moduladores de receptores de glutamato metabotrópicos |
KR101753826B1 (ko) | 2009-05-12 | 2017-07-04 | 얀센 파마슈티칼즈, 인코포레이티드 | 1,2,4―트리아졸로[4,3―a]피리딘 유도체 및 신경정신 질환의 치료 또는 예방을 위한 이들의 용도 |
MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
BRPI1010831A2 (pt) | 2009-05-12 | 2016-04-05 | Addex Pharmaceuticals Sa | derivados de 1,2,4-triazolo[4,3-a]piridina e seu como moduladores alostéricos positivos de receptores de mglur2 |
AU2011328203B2 (en) | 2010-11-08 | 2015-03-19 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
EP2649069B1 (en) | 2010-11-08 | 2015-08-26 | Janssen Pharmaceuticals, Inc. | 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS |
ES2536433T3 (es) | 2010-11-08 | 2015-05-25 | Janssen Pharmaceuticals, Inc. | Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2 |
WO2013192225A1 (en) * | 2012-06-18 | 2013-12-27 | Dart Neuroscience (Cayman) Ltd | Substituted thiophene- and furan-fused azolopyrimidine-5-(6h)-one compounds |
JO3368B1 (ar) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2 |
JO3367B1 (ar) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2 |
MX2016009471A (es) | 2014-01-21 | 2016-10-13 | Janssen Pharmaceutica Nv | Combinaciones que comprenden agonistas ortostericos o moduladores alostericos positivos del receptor glutamatergico metabotropico de subtipo 2 y su uso. |
HUE045610T2 (hu) | 2014-01-21 | 2020-01-28 | Janssen Pharmaceutica Nv | 2-es altípusú metabotróp glutamáterg receptor pozitív allosztérikus modulátorait vagy ortosztérikus agonistáit tartalmazó kombinációk és alkalmazásuk |
JP6420400B2 (ja) * | 2017-04-12 | 2018-11-07 | ダート・ニューロサイエンス・(ケイマン)・リミテッド | 置換ピリジンアゾロピリミジン−5−(6h)−オン化合物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5055465A (en) * | 1989-05-31 | 1991-10-08 | Berlex Laboratories, Inc. | Imidazoquinoxalinones, their aza analogs and process for their preparation |
WO1993020077A1 (en) * | 1992-04-03 | 1993-10-14 | Yamanouchi Pharmaceutical Co., Ltd. | Fused quinoxalinone derivative and pharmaceutical composition containing the same |
DE4228095A1 (de) * | 1992-08-24 | 1994-03-03 | Asta Medica Ag | Neue 4,5-Dihydro-4-oxo-pyrrolo[1,2-a]chinoxaline und entsprechende Aza-analoga und Verfahren zu deren Herstellung |
DE4338948A1 (de) * | 1993-11-15 | 1995-05-18 | Carlen Judith | Verwendung von PDE-Inhibitoren bei der Behandlung erektiler Dysfunktionen |
DE19510965A1 (de) * | 1995-03-24 | 1996-09-26 | Asta Medica Ag | Neue Pyrido/3,2-e/pyrazinone mit antiasthmatischer Wirksamkeit und Verfahren zu deren Herstellung |
DE19728301A1 (de) * | 1997-07-03 | 1999-01-07 | Dresden Arzneimittel | Verwendung von Inhibitoren der Phosphodiesterase 4 für die Behandlung der allergischen Rhinitis |
-
2000
- 2000-03-14 DE DE10012373A patent/DE10012373A1/de not_active Withdrawn
-
2001
- 2001-03-06 CZ CZ20023078A patent/CZ20023078A3/cs unknown
- 2001-03-06 BR BR0109163-8A patent/BR0109163A/pt not_active Application Discontinuation
- 2001-03-06 SK SK1323-2002A patent/SK13232002A3/sk unknown
- 2001-03-06 JP JP2001566661A patent/JP2003528056A/ja active Pending
- 2001-03-06 IL IL15164601A patent/IL151646A0/xx unknown
- 2001-03-06 AU AU2001244192A patent/AU2001244192A1/en not_active Abandoned
- 2001-03-06 EP EP01917067A patent/EP1267877A1/de not_active Withdrawn
- 2001-03-06 WO PCT/EP2001/002485 patent/WO2001068097A1/de not_active Application Discontinuation
- 2001-03-06 RU RU2002127413/04A patent/RU2002127413A/ru unknown
- 2001-03-06 HU HU0300551A patent/HUP0300551A2/hu unknown
- 2001-03-13 AR ARP010101174A patent/AR028250A1/es unknown
-
2002
- 2002-09-10 BG BG107077A patent/BG107077A/bg unknown
- 2002-09-12 NO NO20024364A patent/NO20024364L/no unknown
Also Published As
Publication number | Publication date |
---|---|
BG107077A (bg) | 2003-05-30 |
RU2002127413A (ru) | 2004-02-27 |
IL151646A0 (en) | 2003-04-10 |
AR028250A1 (es) | 2003-04-30 |
EP1267877A1 (de) | 2003-01-02 |
WO2001068097A1 (de) | 2001-09-20 |
NO20024364L (no) | 2002-09-27 |
CZ20023078A3 (cs) | 2003-03-12 |
JP2003528056A (ja) | 2003-09-24 |
AU2001244192A1 (en) | 2001-09-24 |
NO20024364D0 (no) | 2002-09-12 |
SK13232002A3 (sk) | 2003-05-02 |
HUP0300551A2 (hu) | 2003-07-28 |
DE10012373A1 (de) | 2001-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0109163A (pt) | Uso de pirido[3,2-e]-pirazinonas como inibidores da fosfodieterase 5, para terapia de disfunção erétil | |
HK1069169A1 (en) | Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors | |
WO2001087038A3 (en) | β-CARBOLINE DERIVATIVES USEFUL AS INHIBITORS OF PHOSPHODIESTERASE | |
MX9703868A (es) | Inhibidores de cgmp-pde para el tratamiento de disfuncion erectil. | |
SV2003001173A (es) | 1-alquil o 1-cicloalquil-triazolo [4,3-a] quinazolin-5- onas como inhibidoras de fosfodiesterasa | |
BR9915532A (pt) | Inibidores de cgmp pde5 de pirazolopirimidinona para tratamento da disfunção sexual | |
MY126917A (en) | Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors | |
HK1050899A1 (en) | Pteridine compounds for the treatment of psoriasis | |
BR0114903A (pt) | 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação | |
ZA200007019B (en) | Use of prostaglandin agonists to treat erectile dysfunction or impotence. | |
UY27203A1 (es) | Bencimidazoles útiles en el tratamiento de la disfunción sexual | |
DK1109814T3 (da) | 5-Heterocyclylpyrazolo[4,3-d]pyrimidin-7-oner til behandling af mandlig erektil dysfunktion | |
MXPA03002909A (es) | Compuestos quimicos. | |
NZ530587A (en) | Diazacycloalkanes as oxytocin agonists | |
MXPA02012470A (es) | Inhibidores de fosfodiesterasa especificos para gmp ciclico. | |
MXPA02012911A (es) | Compuestos de rutenio (ii) para el uso en terapia del cancer. | |
BRPI0414701A (pt) | uso de um composto de vitamina d, método de prevenção ou tratamnento de disfunção de bexiga em um paciente, composto de vitamina d, e, kit | |
PT1335730E (pt) | Tratamento da ejaculacao prematura | |
AU2001237379A1 (en) | Use of benzothieno-2,3-D-pyrimidines with PDE V inhibitory effect for the treatment of erectile dysfunction | |
BR0206896A (pt) | Derivados de beta-carbolina úteis como inibidores de fosfodiesterase | |
BR0314031A (pt) | Tratamento de rinite não-alérgica por inibidores seletivos de fosfodiesterase 4 | |
UY27411A1 (es) | 1-alquil o 1-cicloalquil-triazolo (4, 3-a) quinazolin-5-onas como inhibidoras de fosfodiesterasa. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |